Occupational respiratory cancers;Cancers respiratoires professionnels

Revue des Maladies Respiratoires

Volumn 25, Issue 2, 2008, Pages 193-207

  Pairon, J C ^a,b,c   Andujar, P ^a,b,c   Matrat, M ^a,b,c   Ameille, J ^d,e  

^a INSERM   (France)

^b CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

^c FACULTÉ DE MÉDECINE   (France)

^d RAYMOND POINCARÉ HOSPITAL   (France)

^e LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

Author keywords

Asbestos; Carcinogens; Lung; Occupational diseases; Silicon dioxide

Indexed keywords

ASBESTOS;

HEALTH PROGRAM; HUMAN; LUNG CANCER; OCCUPATIONAL EXPOSURE; OCCUPATIONAL LUNG DISEASE; PLEURA MESOTHELIOMA; PRIMARY PREVENTION; REVIEW; WORK ENVIRONMENT;

EID: 44349115019     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0761-8425(08)71517-1     Document Type: Article

References (120)

1. CNAM-TS. Statistiques trimestrielles des accidents du travail. Paris 2006, 73 pages.
2. Goldberg M, Imbernon E, Rolland P, Gilg Soit Ilg A, Saves M, de Quillacq A, Frenay C, Chamming’s S, Arveux P, Boutin C, Launoy G, Pairon JC, Astoul P, Galateau-Salle F, Brochard P : The French National Mesothelioma Surveillance Program. Occup Environ Med 2006 ; 63 : 390-5.
3. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB : Cancer incidence in five continents vol. VIII. IARC Scientific Publications N°155 . Lyon, France, 2002, 781 pages.
4. INSERM. Cancer. Approche méthodologique du lien avec l’environnement. Expertise collective. Editions INSERM, Paris, 2005, 92 pages.
5. Peto J, Hodgson JT, Matthews FE, Jones JR : Continuing increase in mesothelioma mortality in Britain. Lancet 1995 ; 345 : 535-9.
6. Peto J, Decarli A, La Vecchia C, Levi F, Negri E : The European mesothelioma epidemic. Br J Cancer 1999 ; 79 : 666-72.
7. Gilg Soit Ilg A, Bignon J, Valleron AJ : Estimation of the past and future burden of mortality from mesothelioma in France. Occup Environ Med 1998 ; 55 : 760-5.
8. Weill H, Hughes JM, Churg AM : Changing trends in US mesothelioma incidence. Occup Environ Med 2004 ; 61 : 438-41.
9. Hodgson JT, McElvenny DM, Darnton AJ, Price MJ, Peto J : The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050. Br J Cancer 2005 ; 92 : 587-93.
10. Segura O, Burdorf A, Looman C : Update of predictions of mortality from pleural mesothelioma in the Netherlands. Occup Environ Med 2003 ; 60 : 50-5.
11. Remontet L, Esteve J, Bouvier AM, Grosclaude P, Launoy G, Menegoz F, Exbrayat C, Tretare B, Carli PM, Guizard AV, Troussard X, Bercelli P, Colonna M, Halna JM, Hedelin G, Mace-Lesec’h J, Peng J, Buemi A, Velten M, Jougla E, Arveux P, Le Bodic L, Michel E, Sauvage M, Schvartz C, Faivre J : Cancer incidence and mortality in France over the period 1978-2000. Rev Epidemiol Sante Publique 2003 ; 51 : 3-30.
12. Imbernon E : Estimation du nombre de cas de certains cancers attribuables à des facteurs professionnels en France. Institut de Veille Sanitaire, Saint Maurice, 2003, 28 pages.
13. Axelson O : Alternative for estimating the burden of lung cancer from occupational exposures – some calculations based on data from Swedish men. Scand J Work Environ Health 2002 ; 28 : 58-63.
14. Nurminen M, Karjalainen A : Epidemiologic estimate of the proportion of fatalities related to occupational factors in Finland. Scand J Work Environ Health 2001 ; 27 : 161-213.
15. Astoul P, Ménard O : Quels critères diagnostiques pour le mésothéliome pleural malin ? Rev Mal Respir 2006 ; 23 : 11S29-35 .
16. Galateau-Sallé F, Copin MC, Delajartre AY, Vignaud JM, Astoul P, Pairon JC, Le Pimpec-Barthes F, Brochard P. Quels critères pour le diagnostic anatomopathologique du mésothéliome pleural malin ? Rev Mal Respir 2006 ; 23 : 11S37-44.
17. Robinson BW, Creaney J, Lake R, Nowak A, Musk AW, de Klerk N, Winzell P, Hellstrom KE, Hellstrom I : Mesothelin-family proteins and diagnosis of mesothelioma. Lancet 2003 ; 362 : 1612-6.
18. Pass HI, Lott D, Lonardo F, Harbut M, Liu Z, Tang N, Carbone M, Webb C, Wali A : Asbestos exposure, pleural mesothelioma, and serum osteopontin levels. N Eng J Med 2005 ; 353 : 1564-73.
19. Grigoriu BD, Scherpereel A, Devos P, Chahine B, Letourneux M, Lebailly P, Grégoire M, Porte H, Copin MC, Lassalle P : Utility of osteopontin and serum mesothelin in malignant pleural mesothelioma diagnosis and prognosis assessment. Clin Cancer Res 2007 ; 13 : 2928-35.
20. Scherpereel A, Lee YG : Biomarkers for mesothelioma. Curr Opin Pulm Med 2007 ; 13 : 339-43.
21. Wagner JC, Sleggs CA, Marchand P : Diffuse pleural mesothelioma and asbestos exposure in the north western Cape Province. Br J Ind Med 1960 ; 17 : 260-71.
22. ARC. IARC monographs on the evaluation of the carcinogenic risks to humans. Asbestos. IARC, Lyon, France, 1977 ; 14 : 106 pages.
23. INSERM. Effets sur la santé des principaux types d’exposition à l’amiante. Expertise collective. Editions INSERM, Paris, 1997, 434 pages.
24. Bourdes V, Boffetta P, Pisani P : Environmental exposure to asbestos and risk of pleural mesothelioma: review and meta-analysis. Eur J Epidemiol 2000 ; 16 : 411-7.
25. Pairon JC, Jaurand MC, Laurent F, Salmi R, Astoul P, Galateau-Sallé F, Brochard P : Comment évaluer une exposition à l’amiante et identifier une exposition à risque ? Rev Mal Respir 2006 ; 23 : 11S9-27.
26. Conférence de consensus pour l’élaboration d’une stratégie de surveillance médicale clinique des personnes exposées à l’amiante. Rev Mal Respir 1999 ; 16 : 1183-388.
27. Iwatsubo Y, Pairon JC, Boutin C, Ménard O, Massin N, Caillaud D, Orlowski E, Galateau-Salle F, Bignon J, Brochard P : Pleural mesothelioma : dose-response relation at low levels of asbestos exposure in a french population-based case-control study. Am J Epidemiol 1998 ; 148 : 133-42.
28. Metintas S, Metintas M, Ucgun I, Oner U : Malignant mesothelioma due to environmental exposure to asbestos: follow-up of a Turkish cohort living in a rural area. Chest 2002 ; 122 : 2224-9.
29. Comba P, Gianfagna A, Paoletti L : Pleural mesothelioma cases in Biancavilla are related to a new fluoro-edenite fibrous amphibole. Arch Environ Health. 2003 ; 58 : 229-32.
30. IARC. IARC Monographs on the evaluation of carcinogenic risks to humans. Man-made vitreous fibres. IARC, Lyon, France, 2002 ; 81 : 418 pages.
31. Cavazza A, Travis LB, Travis WD, Wolfe JT, Foo ML, Gillespie DJ, Weidner N, Colby TV : Post-irradiation malignant mesothelioma . Cancer 1996 ; 77 : 1379-85.
32. Travis LB, Fossa SD, Schonfeld SJ, McMaster ML, Lynch CF, Storm H, Hall P, Holowaty E, Andersen A, Pukkala E, Andersson M, Kaijser M, Gospodarowicz M, Joensuu T, Cohen RJ, Boice JD Jr, Dores GM, Gilbert ES : Second cancers among 40,576 testicular cancer patients: focus on long-term survivors. J Natl Cancer Inst 2005 ; 97 : 1354-65.
33. Tward JD, Wendland MM, Shrieve DC, Szabo A, Gaffney DK : The risk of secondary malignancies over 30 years after the treatment of non–Hodgkin lymphoma. Cancer 2006 ; 107 : 108-15.
34. Andersson M, Wallin H, Jönsson M, Nielsen LL, Visfeldt J, Vyberg M, Bennett WP, De Benedetti VM, Travis LB, Storm HH : Lung carcinoma and malignant mesothelioma in patients exposed to Thorotrast: incidence, histology and p53 status. Int J Cancer 1995 ; 63 : 330-6.
35. Van Kaick G, Dalheimer A, Hornik S, Kaul A, Liebermann D, Lührs H, Spiethoff A, Wegener K, Wesch H : The german thorotrast study : recent results and assessment of risks. Radiat Res 1999 ; 152 : S64-71.
36. Carbone M, Pass HI, Rizzo P, Marinetti MR, Di Muzio M, Mew DJY, Levine AS, Procopio A : Simian virus 40-like DNA sequences in human pleural mesothelioma. Oncogene 1994 ; 9 : 1781-90.
37. Carbone M, Pass HI, Miele L, Bocchetta M : New developments about the association of SV40 with human mesothelioma. Oncogene 2003 ; 22 : 5173-80.
38. Gazdar AF, Carbone M : Molecular pathogenesis of malignant mesothelioma and its relationship to simian virus 40. Clin Lung Cancer 2003 ; 5: 177-81.
39. Stratton K, Alamario DA, McCormick MC : Immunization Safety Review. SV40 contamination of polio vaccine and cancer. Institute of Medicine of the National Academies. The National Academic Press, Washington D.C., 2002.
40. Lopez-Rios F, Illei PB, Rusch V, Ladanyi M : Evidence against a role for SV40 infection in human mesotheliomas and high risk of false-positive PCR results owing to presence of SV40 sequences in common laboratory plasmids. Lancet 2004 ; 364 : 1157-66.
41. McNees AL, White ZS, Zanwar P, Vilchez RA, Butel JS : Specific and quantitative detection of human polyomaviruses BKV, JCV, and SV40 by real time PCR. J Clin Virol 2005 ; 34 : 52-62.
42. Vilchez RA, Butel JS : Emergent human pathogen simian virus 40 and its role in cancer. Clin Microbiol Rev 2004 ; 17 : 495-508.
43. Vilchez RA, Kozinetz CA, Arrington AS, Madden CR, Butel JS : Simian virus 40 in human cancers. Am J Med 2003 ; 114 : 675-84.
44. Magnani C : SV40, genetic polymorphism and mesothelioma. pathological and epidemiological evidence. Med Lav 2005 ; 96 : 347-53.
45. Huncharek M : Non-asbestos related diffuse malignant mesothelioma. Tumori 2002 ; 88 : 1-9.
46. Roushdy-Hammady I, Siegel J, Emri S, Testa JR, Carbone M : Genetic-susceptibility factor and malignant mesothelioma in the Cappadocian region of Turkey. Lancet 2001 ; 357 : 444-5.
47. Steenland K, Loomis D, Shy C, Simonsen N : Review of occupational lung carcinogens. Am J Ind Med 1996 ; 29 : 474-90.
48. Ameille J, Monnet I, Pairon JC : Cancer bronchopulmonaire. In : Pairon JC, Brochard P, Le Bourgeois JP, Ruffié P . Les cancers professionnels . Tome 1. Margaux Orange, Paris, 2000 : 371-401.
49. Ng Gong M, Christiani DC : Lung cancer. In: Hendrick DJ, Burge PS, Beckett WS, Churg A. Occupational disorders of the lung. Recognition, management and prevention . WB Saunders, Elsevier, 2002 : 305-26.
50. Doll R : Mortality from lung cancer in asbestos workers. Br J Ind Med 1955 ; 12 : 81-86.
51. Camus M, Siemiatycki J, Meek B : Nonoccupational exposure to chrysotile asbestos and the risk of lung cancer. N Engl J Med 1998 ; 338 : 1565-71.
52. Imbernon E, Goldberg M, Bonenfant S, Chevalier A, Guénel P, Vatré R, Dehaye J : Occupational respiratory cancer and exposure to asbestos: a case-control study in a cohort of workers in the electricity and gas industry. Am J Ind Med. 1995 ; 28 : 339-52.
53. Gustavsson P, Jakobsson R, Nyberg F, Pershagen G, Järup L, Scheele P : Occupational exposure and lung cancer risk: an population based case-referent study in Sweden. Am J Epidemiol 2000 ; 152 : 32-40.
54. Gustavsson P, Nyberg F, Pershagen G, Scheele P, Jakobsson R, Plato N : Low-dose exposure to asbestos and lung cancer: dose-response relations and interaction with smoking in an population-based case-referent study in Stockholm, Sweden. Am J Epidemiol 2002 ; 155 : 1016-22.
55. Carel R, Boffetta P, Kauppinen T, Teschke K, Andersen A, Jäppinen P, Pearce N, Rix BA, Bergeret A, Coggon D, Persson B, Szadkowska-Stanczyk I, Kielkowski D, Henneberger P, Kishi R, Facchini LA, Sala M, Colin D, Kogevinas M : Exposure to asbestos and lung and pleural cancer mortality among pulp and paper industry workers. J Occup Environ Med 2002 ; 44 : 579-84.
56. Meguellati-Hakkas D, Cyr D, Stücker I, Févotte J, Pilorget C, Luce D, Guénel P : Lung cancer mortality and occupational exposure to asbestos among telephone linemen: a historical cohort study in France. J Occup Environ Med 2006 ; 48 : 1166-72.
57. Hammond EC, Selikoff IJ, Seidman H : Asbestos exposure, cigarette smoking and death rates. Ann NY Acad Sci 1979 ; 330 : 473-90.
58. Henderson DW, Rantanen J, Barnhart S, Dement JM, De Vuyst P, Hillerdal G, Huuskonen MS, Kivisaari L, Kusaka Y, Lahdensuo A, Langard S, Mowe G, Okubo T, Parker JE, Roggli VL, Rödelsperger K, Rösler J, Tossavainen A, Woitowitz J : Asbestos, asbestosis, and cancer: the Helsinki criteria for diagnosis and attribution. Scand J Work Environ Health 1997 ; 23 : 311-6.
59. Hughes JM, Weill H : Asbestosis as a precursor of asbestos-related cancer: results of a prospective mortality study. Br J Ind Med 1991 ; 48 : 229-33.
60. Ameille J, Brochard P, Pairon JC : Amiante et pathologie professionnelle. Masson, Paris, 2000, 187 pages.
61. Wilkinson P, Hansell D, Janssens J, Rubens M, Rudd RM, Taylor AN, Mc Donald C : Is lung cancer associated with asbestos exposure when there are no small opacities on the chest radiograph ? Lancet 1995 ; 345 : 1074-8.
62. Finkelstein MM : Radiographic asbestosis is not a prerequisite for asbestos-associated lung cancer in Ontario asbestos-cement workers. Am J Ind Med 1997 ; 32 : 341-8.
63. Egilman D, Reinert A : Lung cancer and asbestos exposure: asbestosis is not necessary. Am J Ind Med 1996 ; 30 : 398-406.
64. Oksa P, Klockars M, Karjalainen A, Huuskonen MS, Vattulainen K, Pukkala E, Nordman H : Progression of asbestosis predicts lung cancer. Chest 1998 ; 113 : 1517-21.
65. American Thoracic Society Documents. Diagnosis and Initial Management of Nonmalignant Diseases related to asbestos. Am J Respir Crit Care Med 2004 ; 170 : 691-715.
66. INSERM. Effets sur la santé des fibres de substitution à l’amiante. Expertise collective. Editions INSERM, Paris, 1998, 432 pages.
67. Marsh G, Stone RA, Youk A, Smith TJ, Quinn MM, Henderdon V, Schall L, Wayne L, Lee K : Mortality among United States rock wool and slag wool workers: 1989 update. J Occup Health Safety NZ 1996; 12 : 297-312.
68. Marsh GM, Youk AO, Stone RA, Buchanich JM, Gula MJ, Smith TJ, Quinn MM : Historical cohort study of US man-made vitreous fiber production workers: I. 1992 fiberglass cohort follow-up: initial findings. J Occup Environ Med 2001 ; 43 : 741-56.
69. Consonni D, Boffetta P, Andersen A, Chang-Claude J, Cherrie JW, Ferro G, Frentzel-Beyme R, Hansen J, Olsen J, Plato N, Westerholm P, Saracci R : Lung cancer mortality among European rock/slag wool workers: exposure-response analysis. Cancer causes control 1998 ; 9 : 411-6.
70. Kjaerheim K, Boffetta P, Hansen J, Cherrie J, Chang-Claude J, Eilber U, Ferro G, Guldner K, Olsen JH, Plato N, Proud L, Saracci R, Westerholm P, Andersen A : Lung cancer among rock and slag wool production workers. Epidemiology 2002 ; 13 : 445-53 .
71. Stone RA, Youk AO, Marsh GM, Buchanich JM, Smith TJ : Historical cohort study of US man-made vitreous fiber production workers. IX: summary of 1992 mortality follow up and analysis of respiratory system cancer among female workers. J Occup Environ Med 2004 ; 46 : 55-67.
72. Stone RA, Youk AO, Marsh GM, Buchanich JM, McHenry MB, Smith TJ : Historical cohort study of US man-made vitreous fiber production workers. IV: Quantitative exposure-response analysis of the nested case-control study respiratory system cancer. J Occup Environ Med 2001 ; 43 : 779-92.
73. Shannon H, Muir A, Haines T, Verma D : Mortality and cancer incidence in Ontario glass fiber workers. Occup Med 2005 ; 55 : 528-34.
74. Pohlabeln H, Jöckel KH, Brüske-Hohlfeld I, Möhner M, Ahrens W, Bolm-Audorff U, Arhelger R, Romer W, Kreienbrock L, Kreuzer M, Jahn I, Wichmann HE : Lung cancer and exposure to man-made vitreous fibers: results from a pooled case-control study in Germany. Am J Ind Med 2000 ; 37 : 469-77.
75. Brüske-Hohlfeld I, Möhner M, Pohlabeln H, Ahrens W, Bolm-Audorff U, Kreienbrock L, Kreuzer M, Jahn I, Wichmann HE, Jockel KH : Occupational lung cancer risk for men in Germany: results from a pooled case-control study. Am J Epidemiol 2000 ; 151 : 384-95.
76. LeMasters GK, Lockey JE, Yiin JH, Hilbert TJ, Levin LS, Rice CH : Mortality of workers occupationally exposed to refractory ceramic fibers. J Occup Environ Med 2003 ; 45 : 440-50.
77. IARC. IARC Monographs on the evaluation of carcinogenic risks to humans. Silica, some silicates, coal dust and para-aramid fibrils . IARC, Lyon, France, 1997 ; 68 : 506 pages.
78. Soutar CA, Robertson A, Miller BG, Searl A, Bignon J : Epidemiological evidence on the carcinogenicity of silica: factors in scientific judgement. Ann Occup Hyg 2000 ; 44 : 3-14.
79. Steenland K, Mannetje A, Boffetta P, Stayner L, Attfield M, Chen J, Dosemeci M, DeKlerk N, Hnizdo E, Koskela R, Checkoway H; International Agency for Research on Cancer. Pooled exposure-response analyses and risk assessment for lung cancer in 10 cohorts of silica-exposed workers: an IARC multicentre study. Cancer Causes Control 2001 ; 12 : 773-84.
80. Lacasse Y, Martin S, Simard S, Desmeules M : Meta-analysis of silicosis and lung cancer. Scand J Work Environ Health 2005 ; 31 : 450-8.
81. Pelucchi C, Pira E, Piolatto G, Coggiola M, Carta P, La Vecchia C : Occupational silica exposure and lung cancer risk: a review of epidemiological studies 1996-2005. Ann Oncol 2006 ; 17 : 1039-50.
82. Armstrong B, Hutchinson E, Unwin J, Fletcher T : Lung cancer risk after exposure to polycyclic aromatic hydrocarbons: a review and meta-analysis. Environ Health Perspect 2004 ; 112 : 970-8 .
83. Bhatia R, Lopipero P, Smith AH : Diesel exhaust exposure and lung cancer. Epidemiology 1998 ; 9 : 84-91.
84. Lipsett M, Campleman S : Occupational exposure to diesel exhaust and lung cancer: a meta-analysis. Am J Public Health 1999 ; 89 : 1009-17.
85. IARC. IARC monographs on the evaluation of the carcinogenic risks to humans. Tobacco smoke and involuntary smoking. IARC, Lyon, France, 2004 ; 83 : 1452 pages.
86. IARC. IARC Monographs on the evaluation of carcinogenic risks to humans. Beryllium, cadmium, mercury, and exposures in the glass manufacturing industry. IARC, Lyon, France, 1993 ; 58 : 444 pages.
87. Sorahan T, Lister A, Gilthorpe MS, Harrington JM : Mortality of copper cadmium alloy workers with special reference to lung cancer and non-malignant disease of the respiratory system, 1946-92. Occup Environ Med 1995 ; 52 : 804-12.
88. Verougstraete V, Lison D, Hotz P : Cadmium, lung and prostate cancer: a systematic review of recent epidemiological data. J Toxicol Environ Health B Crit Rev 2003 ; 6 : 227-55.
89. Sorahan T, Lancashire RJ : Lung cancer mortality in an cohort of workers employed at a cadmium recovery plant in the United States: an analysis with detailed job histories. Occup Environ Med 1997 ; 54 : 194-201.
90. Moulin JJ, Wild P, Romazini S, Lasfargues G, Peltier A, Bozec C, Deguerry P, Pellet F, Perdrix A : Lung cancer risk in hard-metal workers. Am J Epidemiol 1998 ; 148 : 241-8.
91. Wild P, Perdrix A, Romazini S, Moulin JJ, Pellet F : Lung cancer mortality in a site producing hard metals. Occup Environ Med 2000 ; 57 : 568-73.
92. IARC. IARC Monographs on the evaluation of carcinogenic risks to humans. Cobalt in hard-metals and cobalt sulfate, gallium arsenide, indium phosphide and vanadium pentoxide . IARC, Lyon, France, 2006 ; 86 : 330 pages.
93. IARC. IARC Monographs on the evaluation of carcinogenic risks to humans. Some Organic Solvents, Resin Monomers and Related Compounds, Pigments and Occupational Exposures in Paint Manufacture and Painting . IARC, Lyon, France, 1989 ; 47 : 535 pages.
94. Dalphin JC, Pairon JC, Lemarié E, Ameille J : Questionnaire de repérage des expositions professionnelles chez les sujets atteints de cancer bronchique primitif. Inforespiration 2002 ; 47 : 12-22.
95. Pairon JC, Dumortier P : Place des analyses biométrologiques dans l’évaluation rétrospective des expositions à l’amiante. Rev Mal Respir 1999 ; 16 : 1219-35.
96. Nelson HH, Christiani DC, Wiencke JK, Mark EJ, Wain JC, Kelsey KT : K-ras mutation and occupational asbestos exposure in lung adenocarcinoma: asbestos-related cancer without asbestosis. Cancer Res 1999 ; 59 : 4570-3.
97. Nymark P, Wikman H, Ruosaari S, Hollmén J, Vanhala E, Karjalainen A, Anttila S, Knuutila S : Identification of specific gene copy number changes in asbestos-related lung cancer. Cancer Res 2006 ; 66 : 5737-43.
98. Wikman H, Ruosaari S, Nymark P, Sarhadi VK, Saharinen J, Vanhala E, Karjalainen A, Hollmén J, Knuutila S, Anttila S : Gene expression and copy number profiling suggests the importance of alllelic imbalance in 19p in asbestos-associated lung cancer. Oncogene 2007 ; 26 : 4730-7.
99. er février 2001 établissant les règles particulières de prévention des risques cancérogènes, mutagènes ou toxiques pour la reproduction et modifiant le code du travail (deuxième partie : Décrets en Conseil d’Etat). JORF du 3 février 2001 : 1866-8.
100. Décret n°93-644 du 26 mars 1993 modifiant et complétant certaines dispositions du livre IV du code de la Sécurité sociale et relatif à la surveillance post-professionnelle (deuxième partie : Décrets en Conseil d’Etat). JORF du 28 mars 1993 : 5368.
101. Arrêté du 28 février 1995 pris en application de l’article D461-25 du code de la Sécurité sociale fixant le modèle d’attestation d’exposition et les modalités d’examen dans le cadre du suivi post-professionnel des salariés ayant été exposés à des agents ou procédés cancérogènes. JORF du 22 mars 1995 : 4474-8.
102. Frost JK, Ball WC Jr, Levin ML, Tockman MS, Baker RR, Carter D, Eggleston JC, Erozan YS, Gupta PK, Khouri NF, Marsh BR, Stitik FP : Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Johns Hopkins study. Am Rev Respir Dis 1984 ; 130 : 549-54.
103. Fontana RS, Sanderson DR, Taylor WF, Woolner LB, Miller WE, Muhm JR, Uhlenhopp MA : Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Mayo Clinic study. Am Rev Respir Dis 1984 ; 130 : 561-5.
104. Flehinger BJ, Melamed MR, Zaman MB, Heelan RT, Perchick WB, Martini N : Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Memorial Sloan-Kettering study. Am Rev Respir Dis 1984 ; 130 : 555-60.
105. Melamed MR, Flehinger BJ, Zaman MB, Heelan RT, Perchick WA, Martini N : Screening for early lung cancer. Results of the Memorial Sloan-Kettering study in New York. Chest 1984 ; 86 : 44-53.
106. Kubik A, Polak J : Lung cancer detection. Results of a randomized prospective study in Czechoslovakia. Cancer 1986 ; 57 : 2427-37.
107. Swensen SJ, Jett JR, Sloan JA, Midthun DE, Hartman TE, Sykes AM, Aughenbaugh GL, Zink FE, Hillman SL, Noetzel GR, Marks RS, Clayton AC, Pairolero PC : Screening for lung cancer with low-dose spiral computed tomography. Am J Respir Crit Care Med 2002 ; 165 : 508-13.
108. International Early Lung Cancer Action Program Investigators, Henschke CI, Yankelevitz DF, Libby DM, Pasmantier MW, Smith JP, Miettinen OS : Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 2006 ; 355 : 1763-71.
109. McCunney RJ : Should we screen for occupational lung cancer with low-dose computed tomography? J Occup Environ Med 2006 ; 48 : 1328-33.
110. Black WC, Baron JA : CT screening for lung cancer: spiralling into confusion? JAMA 2007 ; 297 : 995-7.
111. Silvestri GA : Screening for lung cancer in a high risk group: but I still haven’t found what I’m looking for… Eur Respir J 2007 ; 29 : 6-7.
112. Unger M : A pause, progress, and reassessment in lung cancer screening. N Eng J Med 2006 ; 355 : 1822-4.
113. Thiberville L, Salun M, Corne F, Bota S : Les explorations endoscopiques respiratoires en fluorescence. Rev Mal Respir 2006 ; 23 : 16S17-22.
114. Abadia G, Gayet C, Delemotte B, Delépine A, Leprince A, Michiels F, Payan D : Les maladies professionnelles. Guide d’accès aux tableaux du régime général et du régime agricole. INRS ED 835, Paris, 2007, 352 pages.
115. Chamming’s S, Bertin N, Rolland P, Astoul P, Brochard P, Galateau-Sallé F, Launoy G, Gilg Soit Ilg A, Goldberg M, Imbernon E, Iwatsubo Y, Valeyre D, Pairon JC : Impact du PNSM sur la prise en charge médico-sociale des mésothéliomes pleuraux, 1999-2001. Bull Epidemiol Hebd 2003 ; 40 : 187-8.
116. Bergeret A, Nargues P, Solvignon L, Hours M, Févotte J, Danache B, Ayzac L, Monestier F, Gary Y : Enquête sur la réparation des cancers professionnels indemnisables dans le Rhône. Arch Mal Prof 1994 ; 55 : 571-7.
117. Matrat M, Kulichenski ML, Bréchot JM, Couedic K, De Clavière C, Housset B, Iwatsubo Y, Joly N, Lebeau B, Legrand-Cattan K, Lessellier D, Monnet I, Valeyre D, Pairon JC : Evaluation de la reconnaissance en maladie professionnelle de 912 patients atteints de cancer broncho-pulmonaire pris en charge dans 4 hôpitaux d’Ile de France. Rev Mal Respir 2005 ; 22 : 1S122 .
118. Legrand-Cattan K, Chouaïd C, Monnet I, Atassi K, Bassinet L, Dhissi G, Fuhrman C, Lebargy F, L’Huillier JP, Maitre B, Mangiapan G, Roos F, Bignon J, Housset B, Pairon JC : Evaluation des expositions professionnelles et cancer bronchopulmonaire. Rev Mal Respir 2000 ; 17 : 957-62.
119. De Lamberterie G, Maître A, Goux S, Brambilla C, Perdrix A : Démarche pour réduire la sous-déclaration des cancers bronchiques professionnels. A propos d’une expérience pilote menée au CHU de Grenoble de 1996 à 1998. Rev Mal Respir 2002 ; 19 : 190-5.